Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $16.1200 0.1000 % 0.6200 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 0.62% […]
Read MoreArdelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. ARDX $4.0500 0.0200 % 0.5000 Ardelyx Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 0.5% Wk: 13.76% Mo: 34.55% Yrly: […]
Read MoreAssertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inflammation. ASRT $6.1800 0.5000 % 8.8000 Assertio Therapeutics Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 8.8% Wk: -4.7% Mo: 12.03% Yrly: 161.75% YTD: 32.09% […]
Read MoreArdelyx, Inc. (ARDX) Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. Karyopharm Therapeutics Inc. (KPTI) Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. Aldeyra […]
Read MoreBuy Price: $16.12 or better Sell Price: TradersPro Sell Signal Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. The stocks found in the One Hot Stock category use stocks that are in long term, short term trends and are early in the buy signal trend. Suggested buy prices are […]
Read MoreCymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CBAY $8.5900 0.4900 % 6.0500 Cymabay Therapeutics Sector : Medical Industry : Medical – Generic Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 6.05% Wk: 6.84% Mo: 0.7% Yrly: 164.31% YTD: […]
Read MoreCatalent, Inc. (CTLT) Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. AlloVir, Inc. (ALVR) Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat […]
Read MoreArdelyx, Inc. (ARDX) Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. Savara Inc. (SVRA) Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTIC $5.9500 0.1400 % 2.4100 Cti Biopharm Corp Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 2.41% Wk: 0.35% Mo: […]
Read MoreMarket conditions are Mildly bullish in a Bear Market as of 2023-01-20. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -11.64 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $18.7200 0.1700 % 0.9200 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 0.92% […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTIC $6.0100 0.2200 % 3.8000 Cti Biopharm Corp Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 3.8% Wk: 5.44% Mo: […]
Read MoreStevanato Group S.p.A. (STVN) Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. Collegium Pharmaceutical, Inc. (COLL) […]
Read MoreMarket conditions are Mildly bullish in a Bear Market as of 2022-12-12. This means traders and investors should consider trading with a Neutral or Bullish bias by buying stocks and setting tight stops. The rank of the Bear Market is -14.11 which indicates the current market conditions are Extreme, Risk of a reversal is high. […]
Read MoreUnited Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. UTHR $278.4200 -2.0100 % -0.7200 United Therapeutic Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend […]
Read More